Advertisement

Informed deferral: A moral requirement for entry into the hepatitis C virus treatment warehouse

Authors

  • Andrew Aronsohn M.D.,

    Corresponding author
    1. Center for Liver Disease, Section of Gastroenterology, Hepatology and Nutrition, University of Chicago Medical Center, Chicago, IL
    2. MacLean Center for Clinical Medical Ethics, University of Chicago Medical Center, Chicago, IL
    • Center for Liver Disease, Section of Gastroenterology, Hepatology and Nutrition, University of Chicago Medical Center, 5841 South Maryland Avenue, MC 7120, Chicago, IL 60637
    Search for more papers by this author
    • fax: 773-834-1288

  • Donald Jensen M.D.

    1. Center for Liver Disease, Section of Gastroenterology, Hepatology and Nutrition, University of Chicago Medical Center, Chicago, IL
    Search for more papers by this author

  • Potential conflict of interest: Dr. Jensen consults for and received grants from Abbott, Bristol-Myers Squibb, Boehringer-Ingelheim, Genentech, and Tibotec. He consults for Astex, Biotica, Gilead, Inhibitex, and Merck. He also have others interests with Consensus Medical Communication and Clinical Care Options.

No abstract is available for this article.

Ancillary